Cardiac resynchronization therapy with a defibrillator (CRT-D) is associated with “significant improvements” in mortality and heart failure (HF) hospitalization rates among…

The University of California San Diego Health has debuted a new technology that may offer a better way to assess and treat…

Medtronic has gained an expanded FDA approval for its Freezor and Freezor Xtra…

Cleveland Clinic shared its annual list of 10 medical innovations expected to make a big impact on patient care in 2022. While the analysis covers multiple areas, including mRNA technology and…

The presence of myocardial fibrosis (MF) on cardiac MRI (CMR) can help anticipate adverse…

Abbott announced the world's first patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2 FDA pivotal clinical study. The implant of Abbott's investigational Aveir dual-chamber leadless pacemaker represents a…

Biotricity, a California-based healthcare technology company, has received FDA clearance for its new three-lead electrocardiogram (ECG) and arrhythmia monitoring solution.

The Biotres Cardiac Monitoring Device was built to help monitor…

Many recovered COVID-19 patients still show signs of right ventricular dysfunction and diastolic dysfunction three months after hospitalization, according to a new study published in the Journal of the American Heart Association.…

Patients who receive a secondary prevention implantable cardioverter defibrillator (ICD) may be able to start driving again a little earlier than previously believed, according to a new study published in Circulation.

The…

Sudden cardiac death (SCD) cases are very rarely associated with having sex among younger individuals, according to a new analysis published in JAMA Cardiology.

The study’s authors examined data from nearly 7,000 SCD cases…

Royal Philips has announced its plans to collaborate with the American Heart Association (AHA) to boost awareness about cardiovascular implantable electronic device (CIED) infections.

A majority of patients in…

Abbott has received FDA clearance for its new cardiac mapping solution fort the electrophysiology (EP) lab that provides users with 3D representations of the patient’s entire…

Apixaban is associated with lower rates of major and gastrointestinal bleeding than rivaroxaban in patients with nonvalvular atrial fibrillation (NVAF), according to a new meta-analysis published in the American Journal of Cardiology…

Direct oral anticoagulants (DOACs) aren’t prescribed to frail atrial fibrillation (AFib) patients as much as they should be, according to a new study published in the Canadian Journal of Cardiology.

In the analysis, researchers…

Treatment with metoprolol may benefit patients with obstructive hypertrophic cardiomyopathy (HCM), according to a new study published in the Journal of the American College of Cardiology.

According to the authors, their study was…

Implantable cardioverter-defibrillators (ICDs) are underused among female and non-white hypertrophic cardiomyopathy (HCM) patients, according to new research published in Mayo Clinic Proceedings.

The study’s authors examined data…

Risk scores designed to predict atrial fibrillation (AFib) after catheter ablation are largely ineffective, according to new data published in Circulation: Arrhythmia and…

Older adults with a high resting heart rate may face an increased risk of dementia, according to new findings published in Alzheimer’s & Dementia.

The study included data from more than 2,100 participants who were 60 years…

Patients with cardiac amyloidosis presenting with heart failure and new-onset atrial fibrillation (AFib) may benefit from direct oral anticoagulants (DOACs) more than vitamin K antagonists (VKAs), according to new data published in the …

Older age is a key predictor for major atrial fibrillation (AFib) endpoints among patients with hypertrophic cardiomyopathy (HCM), according to new data published in JACC: Clinical Electrophysiology.

AFib, including atrial…

The world of EP keeps getting busier and busier. Greater visibility, more referrals to electrophysiology for rhythm issues — namely atrial fibrillation (AFib)—and a surge in…